BDRX - Biodexa rallies 80% on positive Phase 2 data for eRapa
2024-05-21 09:40:26 ET
More on Biodexa Pharmaceuticals
- Biodexa shares rally 126% on rapamycin licensing deal
- Biodexa stock slides 7% amid data for two drug studies
- Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals
- Historical earnings data for Biodexa Pharmaceuticals
- Financial information for Biodexa Pharmaceuticals